Exosomal protein interactors as emerging therapeutic targets in urothelial bladder cancer

Conclusions The importance of identifying interactors is that that they can be used as targets for therapy, for example, using Bevacizumab (avastin – an angiogenesis inhibitor) against NF2 to inhibit protein–protein interactions will inhibit tumor growth and progression by hindering the exosome biogenesis.
Source: Journal of the Egyptian National Cancer Institute - Category: Cancer & Oncology Source Type: research